13F Pro

Hedge Funds Similar to Royalty Pharma Sub-Manager

13F Portfolio OverlapQ2 2026Royalty Pharma Sub-Manager portfolio →
Institutional-grade research for retail investors

Most similar hedge funds by 13F overlap

Royalty Pharma Sub-Manager, LLC is an institutional investor managing $242M across 4 U.S. equity positions as of Q2 2026. Based on the overlap of conviction holdings in their latest 13F filings, the hedge funds with portfolios most similar to Royalty Pharma Sub-Manager are Siren, L.L.C., with shared positions in $BCAX, $CYTK, $KLRA. The full ranking of 1 similar funds is below.

#1Siren, L.L.C.Active
Some overlap · 3 shared positions
$BCAX$CYTK$KLRA
$4.9B
117 positions

Compare Royalty Pharma Sub-Manager’s portfolio side by side

See the exact shared positions, conviction overlap, sector alignment, and where these funds diverge — and run the same analysis on any of 8,700+ institutions.

View Royalty Pharma Sub-Manager’s holdings

Similarity is derived from each fund’s latest 13F-HR filing with the SEC. Funds are ranked by the overlap of distinctive conviction holdings; near-universal mega-cap positions are excluded so the ranking reflects shared strategy, not common index exposure. Data is informational only and not investment advice.